Slingshot Insights | Pharmacogenetics Overview

PHARMACOGENETICS Overview

Upcoming Projects (PHARMACOGENETICS)

Don’t see a project related to the keyword you care about? Create your own!

Executed Projects (PHARMACOGENETICS)

A third look at how prescribing patterns will be affected for patients with high cholesterol after FDA clearance for 23andMe’s genetic reports to include predicted patient reaction to simvastatin based on SLCO1B1 genotype.
Ticker: ME
Executed On: Nov 18, 2022 at 03:00 PM EST
A second look at how prescribing patterns will be affected for patients with high cholesterol after FDA clearance for 23andMe’s genetic reports to include predicted patient reaction to simvastatin based on SLCO1B1 genotype.
Ticker: ME
Executed On: Nov 07, 2022 at 11:30 AM EST
A look at how prescribing patterns will be affected for patients with high cholesterol after FDA clearance for 23andMe’s genetic reports to include predicted patient reaction to simvastatin based on SLCO1B1 genotype.
Ticker: ME
Executed On: Nov 03, 2022 at 04:00 PM EDT

Upcoming & Overdue Catalysts (PHARMACOGENETICS)

Don’t see a catalyst related to the keyword you care about? Create your own!

Strategic Initiatives (PHARMACOGENETICS)

Don’t see a strategic initiative related to the keyword you care about? Create your own!